Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Vaccine against H. influenzae offered for licensing

Nov. 26, 1996

NABI to reformulate StaphVAX

Nov. 26, 1996

GBS vaccine proven safe and immunogenic

Nov. 25, 1996

New macrocyclic immunosuppressants from Abbott

Nov. 20, 1996

Astra claims orally active peptide immunomodulators

Nov. 19, 1996

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Nov. 19, 1996

Italian introduction for CellCept

Nov. 15, 1996

Oral tolerance therapy for transplant rejection from AutoImmune to enter clinic

Nov. 15, 1996

Aquila's pneumococcal immunotherapeutic enters clinical trials

Nov. 15, 1996

Lilly to manufacture SangStat generic immunosuppressant

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026